GEODE CAPITAL MANAGEMENT, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$1,645,000
-33.6%
1,382,968
+0.4%
0.00%
Q2 2022$2,479,000
-41.5%
1,377,710
-34.3%
0.00%
-100.0%
Q1 2022$4,235,000
-29.4%
2,096,698
-5.2%
0.00%0.0%
Q4 2021$5,996,000
-33.5%
2,212,612
+9.5%
0.00%0.0%
Q3 2021$9,011,000
-15.9%
2,020,571
+9.4%
0.00%0.0%
Q2 2021$10,711,000
-8.1%
1,846,733
+11.2%
0.00%
-50.0%
Q1 2021$11,655,000
+79.8%
1,660,342
+22.9%
0.00%
+100.0%
Q4 2020$6,484,000
-16.5%
1,350,865
+1.4%
0.00%
-50.0%
Q3 2020$7,763,000
-6.9%
1,331,618
+7.7%
0.00%0.0%
Q2 2020$8,341,000
+43.2%
1,235,845
+35.0%
0.00%0.0%
Q1 2020$5,823,000
-61.1%
915,710
-36.2%
0.00%0.0%
Q4 2019$14,960,000
+431.2%
1,435,164
+100.3%
0.00%
+100.0%
Q3 2019$2,816,000
-72.7%
716,664
+3.4%
0.00%
-50.0%
Q2 2019$10,306,000
-32.9%
693,100
+12.0%
0.00%
-50.0%
Q1 2019$15,363,000
-25.2%
619,011
-45.9%
0.00%
+33.3%
Q4 2018$20,546,000
+31.3%
1,144,008
+114.8%
0.00%
-25.0%
Q3 2018$15,643,000
-32.8%
532,635
+4.0%
0.00%
-42.9%
Q2 2018$23,278,000
-1.2%
511,954
+14.7%
0.01%
-12.5%
Q1 2018$23,569,000
-20.6%
446,397
+2.3%
0.01%
-20.0%
Q4 2017$29,683,000
-17.2%
436,518
+0.3%
0.01%
-23.1%
Q3 2017$35,869,000
-10.1%
435,312
+2.1%
0.01%
-18.8%
Q2 2017$39,909,000
+61.2%
426,247
+9.6%
0.02%
+60.0%
Q1 2017$24,758,000
+91.9%
388,857
+33.9%
0.01%
+66.7%
Q4 2016$12,901,000
+33.8%
290,450
+8.6%
0.01%
+20.0%
Q3 2016$9,643,000
+209.7%
267,491
+17.8%
0.01%
+150.0%
Q2 2016$3,114,000
-25.3%
227,024
+4.6%
0.00%0.0%
Q1 2016$4,167,000
-44.5%
217,062
+1.3%
0.00%
-50.0%
Q4 2015$7,502,000
-63.0%
214,350
-2.9%
0.00%
-66.7%
Q3 2015$20,297,000
+21.6%
220,716
+16.2%
0.01%
+20.0%
Q2 2015$16,688,000
+22.6%
189,899
+3.6%
0.01%
+25.0%
Q1 2015$13,610,000
+39.9%
183,350
+5.6%
0.01%
+33.3%
Q4 2014$9,727,000
+28.0%
173,699
+3.7%
0.01%
+20.0%
Q3 2014$7,600,000
+12.6%
167,554
+2.8%
0.01%
+25.0%
Q2 2014$6,748,000
-38.0%
162,975
+3.7%
0.00%
-42.9%
Q1 2014$10,889,000
+19.7%
157,209
+4.1%
0.01%
+16.7%
Q4 2013$9,099,000
+54.0%
150,985
+55.3%
0.01%
+20.0%
Q3 2013$5,909,000
+12.0%
97,212
+23.4%
0.01%0.0%
Q2 2013$5,275,00078,7580.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders